Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3392-3403
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3392
Table 6 Era 1 and era 2 risk comparisons
Era 1Era 2P value
DCD liver transplants1727
Hypoxic cholangiopathy29.4%63.0%0.030
Transplants per year2.57.10.100
Hepatocellular carcinoma23.5%51.9%0.060
Donor body mass index (kg/m2)24.1 ± 3.126.7 ± 4.30.030
Donor hypoxia accrual time (min)17.3 ± 5.022.7 ± 4.80.001
Donor extubation-to-asystole time (min)9.3 ± 4.514.4 ± 4.70.001
Donor aystole-to-crossclamp time (min)8.1 ± 2.78.3 ± 2.30.779
Donor ischemia time (min)9.7 ± 5.613.9 ± 5.90.030
Donor hypoxemia time (min)11.1 ± 6.716.0 ± 5.10.013
Donor hypoxia score1.6 ± 0.92.7 ± 1.10.003
Donor hypoxia score > 2.028.6%73.1%0.006
Recipient cold ischemia time (min)381 ± 139461 ± 1110.040
Recipient warm ischemia time (min)31 ± 1039 ± 150.030
Recipient total ischemia time (min)411.8 ± 135499.4 ± 1190.030